In order to understand the biochemical basis for cellular responses involving specific genes, it is critical to obtain sufficient quantities of the purified protein products of the genes so that functional and structural studies can be performed. Each of the projects of this SCOR grant involves an attempt to understand a the cellular or animal level the importance of growth factors, receptors and downstream signaling proteins in either vascular development or atherosclerotic plaque formation. In order to fully understand in detail how these signaling cascades mediate cell growth, chemotaxis and adherence it is necessary to determine the functions of these proteins and how they make specific contacts with other cellular proteins. With this knowledge it will ultimately be possible to design drugs to specifically block or enhance signaling cascades involved in vascular development, atherosclerosis or restenosis. The first goal of this core is to express the various signaling proteins that are crucial to the other projects and to purify the proteins. The individual project leaders can then use these proteins for in vitro studies and for raising antibodies. In addition, a novel peptide library approach will be used to ascertain the optimal peptide sequence for binding to the various domains. This information will be used to design inhibitors and to predict in vivo targets of protein kinases and phosphatases involved in vascular signaling.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056993-03
Application #
6110791
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Raj, Satish R; Robertson, David; Biaggioni, Italo et al. (2007) Abnormal valsalva maneuver is not always a sign of congestive heart failure. Am J Med 120:e15-6
Laham, Roger J; Simons, Michael; Pearlman, Justin D et al. (2002) Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization. J Am Coll Cardiol 39:1-8
Ruel, Marc; Laham, Roger J; Parker, J Anthony et al. (2002) Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 124:28-34
Post, Mark J; Laham, Roger J; Kuntz, Richard E et al. (2002) The effect of intracoronary fibroblast growth factor-2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis. Clin Cardiol 25:271-8
Pearlman, Justin D; Laham, Roger J; Post, Mark et al. (2002) Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis. Curr Pharm Des 8:1467-96
Pearlman, J D; Gertz, Z M; Wu, Y et al. (2001) Serial motion assessment by reference tracking (SMART): application to detection of local functional impact of chronic myocardial ischemia. J Comput Assist Tomogr 25:558-62
Laham, R J; Simons, M; Sellke, F (2001) Gene transfer for angiogenesis in coronary artery disease. Annu Rev Med 52:485-502
Hoffmeister, K M; Falet, H; Toker, A et al. (2001) Mechanisms of cold-induced platelet actin assembly. J Biol Chem 276:24751-9
Sato, K; Wu, T; Laham, R J et al. (2001) Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37:616-23
Tonks, N K; Neel, B G (2001) Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13:182-95

Showing the most recent 10 out of 31 publications